Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kurtzke, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kurtzke, J. F.
NEUROLOGY 1983;33:1444
© 1983 American Academy of Neurology

Rating neurologic impairment in multiple sclerosis

An expanded disability status scale (EDSS)

John F. Kurtzke, MD

Neurology Service, Veterans Administration Medical Center and Departments of Neurology and of Community Medicine, Georgetown University School of Medicine, Washington, DC.

One method of evaluating the degree of neurologic impairment in MS has been the combination of grades (0 = normal to 5 or 6 = maximal impairment) within 8 Functional Systems (FS) and an overall Disability Status Scale (DSS) that had steps from 0 (normal) to 10 (death due to MS). A new Expanded Disability Status Scale (EDSS) is presented, with each of the former steps (1,2,3 ... 9) now divided into two (1.0, 1.5, 2.0 ... 9.5). The lower portion is obligatorily defined by Functional System grades. The FS are Pyramidal, Cerebellar, Brain Stem, Sensory, Bowel & Bladder, Visual, Cerebral, and Other; the Sensory and Bowel & Bladder Systems have been revised. Patterns of FS and relations of FS by type and grade to the DSS are demonstrated.

Address correspondence and reprint requests to Dr. Kurtzke, Chief, Neurology Service (127), Veterans Administration Medical Center, 50 Irving Street, NW, Washington, DC 20422.

Accepted for publication February 9, 1983.




This article has been cited by other articles:


Home page
 J. Neurol. Neurosurg. PsychiatryHome page
L Durelli, P Barbero, M Bergui, E Versino, M A Bassano, E Verdun, C Rivoiro, C Ferrero, E Picco, P Ripellino, et al.
MRI activity and neutralising antibody as predictors of response to interferon {beta} treatment in multiple sclerosis
J. Neurol. Neurosurg. Psychiatry, June 1, 2008; 79(6): 646 - 651.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. P. Amato, B. Goretti, A. Ghezzi, S. Lori, V. Zipoli, E. Portaccio, L. Moiola, M. Falautano, M. F. De Caro, M. Lopez, et al.
Cognitive and psychosocial features of childhood and juvenile MS
Neurology, May 13, 2008; 70(20): 1891 - 1897.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
M. Braitch, R. Nunan, G. Niepel, L. J. Edwards, and C. S. Constantinescu
Increased Osteopontin Levels in the Cerebrospinal Fluid of Patients With Multiple Sclerosis
Arch Neurol, May 1, 2008; 65(5): 633 - 635.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. M. Greer, P. A. Csurhes, D. M. Muller, and M. P. Pender
Correlation of Blood T Cell and Antibody Reactivity to Myelin Proteins with HLA Type and Lesion Localization in Multiple Sclerosis
J. Immunol., May 1, 2008; 180(9): 6402 - 6410.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
S Johansson, C Ytterberg, J Hillert, L W. Holmqvist, and L von Koch
A longitudinal study of variations in and predictors of fatigue in multiple sclerosis
J. Neurol. Neurosurg. Psychiatry, April 1, 2008; 79(4): 454 - 457.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
D Horakova, J L Cox, E Havrdova, S Hussein, O Dolezal, D Cookfair, M G Dwyer, Z Seidl, N Bergsland, M Vaneckova, et al.
Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study
J. Neurol. Neurosurg. Psychiatry, April 1, 2008; 79(4): 407 - 414.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
M. D Goldman, R. A. Marrie, and J. A Cohen
Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls
Multiple Sclerosis, April 1, 2008; 14(3): 383 - 390.
[Abstract] [PDF]

Home page
 Mult SclerHome page
T. Matsushita, T. Matsuoka, T. Ishizu, H. Kikuchi, M. Osoegawa, Y. Kawano, F. Mihara, Y. Ohyagi, and J.-i. Kira
Anterior periventricular linear lesions in optic-spinal multiple sclerosis: a combined neuroimaging and neuropathological study
Multiple Sclerosis, April 1, 2008; 14(3): 343 - 353.
[Abstract] [PDF]

Home page
 Mult SclerHome page
H. Tremlett, Yinshan Zhao, and V. Devonshire
Natural history of secondary-progressive multiple sclerosis
Multiple Sclerosis, April 1, 2008; 14(3): 314 - 324.
[Abstract] [PDF]

Home page
 Mult SclerHome page
J. Le Scanff, P. Seve, C. Renoux, C. Broussolle, C. Confavreux, and S. Vukusic
Uveitis associated with multiple sclerosis
Multiple Sclerosis, April 1, 2008; 14(3): 415 - 417.
[Abstract] [PDF]

Home page
 Mult SclerHome page
E. Granieri, C. Monaldini, R. De Gennaro, S. Guttmann, M. Volpini, M. Stumpo, P. Fazio, and I. Casetta
Multiple sclerosis in the Republic of San Marino: a prevalence and incidence study
Multiple Sclerosis, April 1, 2008; 14(3): 325 - 329.
[Abstract] [PDF]

Home page
 Mult SclerHome page
M. Roca, T. Torralva, F. Meli, M. Fiol, M. Calcagno, S. Carpintiero, G. De Pino, F. Ventrice, M. Martin, L. Vita, et al.
Cognitive deficits in multiple sclerosis correlate with changes in fronto-subcortical tracts
Multiple Sclerosis, April 1, 2008; 14(3): 364 - 369.
[Abstract] [PDF]

Home page
 Mult SclerHome page
M. Casadio, V. Sanguineti, P. Morasso, and C. Solaro
Abnormal sensorimotor control, but intact force field adaptation, in multiple sclerosis subjects with no clinical disability
Multiple Sclerosis, April 1, 2008; 14(3): 330 - 342.
[Abstract] [PDF]

Home page
 haematolHome page
S. Imashuku, Y. Shioda, R. Kobayashi, G. Hosoi, H. Fujino, S. Seto, H. Wakita, A. Oka, N. Okazaki, N. Fujita, et al.
Neurodegenerative central nervous system disease as late sequelae of Langerhans cell histiocytosis. Report from the Japan LCH Study Group
Haematologica, April 1, 2008; 93(4): 615 - 618.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
J. J. Kragt, A. J. Thompson, X. Montalban, M. Tintore, J. Rio, C. H. Polman, and B.M.J. Uitdehaag
Responsiveness and predictive value of EDSS and MSFC in primary progressive MS
Neurology, March 25, 2008; 70(13_Part_2): 1084 - 1091.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
L. Bonzano, A. Tacchino, L. Roccatagliata, G. Abbruzzese, G. L. Mancardi, and M. Bove
Callosal Contributions to Simultaneous Bimanual Finger Movements
J. Neurosci., March 19, 2008; 28(12): 3227 - 3233.
[Abstract] [Full Text] [PDF]

Home page
 Clin RehabilHome page
C. P Donnellan and J. Shanley
Comparison of the effect of two types of acupuncture on quality of life in secondary progressive multiple sclerosis: a preliminary single-blind randomized controlled trial
Clinical Rehabilitation, March 1, 2008; 22(3): 195 - 205.
[Abstract] [PDF]

Home page
 Clin RehabilHome page
L. Klassen, C. Schachter, and R. Scudds
An exploratory study of two measures of free-living physical activity for people with multiple sclerosis
Clinical Rehabilitation, March 1, 2008; 22(3): 260 - 271.
[Abstract] [PDF]

Home page
 Mult SclerHome page
L. Costelloe, K. O'Rourke, C. McGuigan, C. Walsh, N. Tubridy, and M. Hutchinson
The longitudinal relationship between the patient-reported Multiple Sclerosis Impact Scale and the clinician-assessed Multiple Sclerosis Functional Composite
Multiple Sclerosis, March 1, 2008; 14(2): 255 - 258.
[Abstract] [PDF]

Home page
 Mult SclerHome page
M. Simeoni, P. Auquier, O. Fernandez, P. Flachenecker, S. Stecchi, C. Constantinescu, E. Idiman, A. Boyko, A. Beiske, T. Vollmer, et al.
Validation of the Multiple Sclerosis International Quality of Life questionnaire
Multiple Sclerosis, March 1, 2008; 14(2): 219 - 230.
[Abstract] [PDF]

Home page
 Mult SclerHome page
Fuhua Peng, Bin Zhang, Xiufeng Zhong, Jin Li, Guihong Xu, Xueqiang Hu, Wei Qiu, and Zhong Pei
Serum uric acid levels of patients with multiple sclerosis and other neurological diseases
Multiple Sclerosis, March 1, 2008; 14(2): 188 - 196.
[Abstract] [PDF]

Home page
 Mult SclerHome page
L. Villar, N. Garcia-Barragan, M. Espino, E. Roldan, M. Sadaba, J. Gomez-Rial, P. Gonzalez-Porque, and J. Alvarez-Cermeno
Influence of oligoclonal IgM specificity in multiple sclerosis disease course
Multiple Sclerosis, March 1, 2008; 14(2): 183 - 187.
[Abstract] [PDF]

Home page
 Mult SclerHome page
S. Strasser-Fuchs, C. Enzinger, S. Ropele, M. Wallner, and F. Fazekas
Clinically benign multiple sclerosis despite large T2 lesion load: Can we explain this paradox?
Multiple Sclerosis, March 1, 2008; 14(2): 205 - 211.
[Abstract] [PDF]

Home page
 Mult SclerHome page
L. Lovrecic, S. Ristic, N. Starcevic-Cizmarevic, B. Brajenovic-Milic, Sasa Sega Jazbec, J. Sepcic, M. Kapovic, and B. Peterlin
PAI and TPA gene polymorphisms in multiple sclerosis
Multiple Sclerosis, March 1, 2008; 14(2): 243 - 247.
[Abstract] [PDF]

Home page
 Mult SclerHome page
M. Summers, L. Fisniku, V. Anderson, D. Miller, L. Cipolotti, and M. Ron
Cognitive impairment in relapsing--remitting multiple sclerosis can be predicted by imaging performed several years earlier
Multiple Sclerosis, March 1, 2008; 14(2): 197 - 204.
[Abstract] [PDF]

Home page
 BrainHome page
L. K. Fisniku, P. A. Brex, D. R. Altmann, K. A. Miszkiel, C. E. Benton, R. Lanyon, A. J. Thompson, and D. H. Miller
Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis
Brain, March 1, 2008; 131(3): 808 - 817.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
M. M. Vellinga, R. D. Oude Engberink, A. Seewann, P. J.W. Pouwels, M. P. Wattjes, S. M.A. van der Pol, C. Pering, C. H. Polman, H. E. de Vries, J. J.G. Geurts, et al.
Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement
Brain, March 1, 2008; 131(3): 800 - 807.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
S. L. Hauser, E. Waubant, D. L. Arnold, T. Vollmer, J. Antel, R. J. Fox, A. Bar-Or, M. Panzara, N. Sarkar, S. Agarwal, et al.
B-Cell Depletion with Rituximab in Relapsing-Remitting Multiple Sclerosis
N. Engl. J. Med., February 14, 2008; 358(7): 676 - 688.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
D.S. Reich, K.M. Zackowski, E.M. Gordon-Lipkin, S.A. Smith, B.A. Chodkowski, G.R. Cutter, and P.A. Calabresi
Corticospinal Tract Abnormalities Are Associated with Weakness in Multiple Sclerosis
AJNR Am. J. Neuroradiol., February 1, 2008; 29(2): 333 - 339.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
R. Zivadinov, A.C. Banas, V. Yella, N. Abdelrahman, B. Weinstock-Guttman, and M.G. Dwyer
Comparison of Three Different Methods for Measurement of Cervical Cord Atrophy in Multiple Sclerosis
AJNR Am. J. Neuroradiol., February 1, 2008; 29(2): 319 - 325.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
C. Di Perri, M. Battaglini, M. L. Stromillo, M. L. Bartolozzi, L. Guidi, A. Federico, and N. De Stefano
Voxel-Based Assessment of Differences in Damage and Distribution of White Matter Lesions Between Patients With Primary Progressive and Relapsing-Remitting Multiple Sclerosis
Arch Neurol, February 1, 2008; 65(2): 236 - 243.
[Abstract] [Full Text] [PDF]

Home page
 Psychosom. Med.Home page
K. van Kessel, R. Moss-Morris, E. Willoughby, T. Chalder, M. H. Johnson, and E. Robinson
A Randomized Controlled Trial of Cognitive Behavior Therapy for Multiple Sclerosis Fatigue
Psychosom Med, February 1, 2008; 70(2): 205 - 213.
[Abstract] [Full Text] [PDF]

Home page
 ptjournalHome page
J. Paltamaa, T. Sarasoja, E. Leskinen, J. Wikstrom, and E. Malkia
Measuring Deterioration in International Classification of Functioning Domains of People With Multiple Sclerosis Who Are Ambulatory
Physical Therapy, February 1, 2008; 88(2): 176 - 190.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
B. Banwell, S. Tenembaum, V. A. Lennon, E. Ursell, J. Kennedy, A. Bar-Or, B. G. Weinshenker, C. F. Lucchinetti, and S. J. Pittock
Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders
Neurology, January 29, 2008; 70(5): 344 - 352.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. A. Rocca, P. Tortorella, A. Ceccarelli, A. Falini, D. Tango, G. Scotti, G. Comi, and M. Filippi
The "mirror-neuron system" in MS: A 3 tesla fMRI study
Neurology, January 22, 2008; 70(4): 255 - 262.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
A. D. Sadovnick and D. H. Jacobs
MS and cognition and APOE: The ongoing conundrum about biomarkers
Neurology, January 15, 2008; 70(3): 164 - 165.
[Full Text] [PDF]

Home page
 QJMHome page
R.J. Mills and C.A. Young
A medical definition of fatigue in multiple sclerosis
QJM, January 14, 2008; (2008) hcm122v1.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
R.W. Motl, P.A. Arnett, M.M. Smith, F.H. Barwick, B. Ahlstrom, and E.J. Stover
Worsening of symptoms is associated with lower physical activity levels in individuals with multiple sclerosis
Multiple Sclerosis, January 1, 2008; 14(1): 140 - 142.
[Abstract] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
E. Le Page, E. Leray, G. Taurin, M. Coustans, J. Chaperon, S. P Morrissey, and G. Edan
Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patients
J. Neurol. Neurosurg. Psychiatry, January 1, 2008; 79(1): 52 - 56.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
K. Rejdak, A. Petzold, Z. Stelmasiak, and G. Giovannoni
Cerebrospinal fluid brain specific proteins in relation to nitric oxide metabolites during relapse of multiple sclerosis
Multiple Sclerosis, January 1, 2008; 14(1): 59 - 66.
[Abstract] [PDF]

Home page
 Mult SclerHome page
M. Manconi, M.A. Rocca, L. Ferini-Strambi, P. Tortorella, F. Agosta, G. Comi, and M. Filippi
Restless legs syndrome is a common finding in multiple sclerosis and correlates with cervical cord damage
Multiple Sclerosis, January 1, 2008; 14(1): 86 - 93.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
E. R. Hammond and D. A. Kerr
Ethanol Responsive Tremor in a Patient With Multiple Sclerosis
Arch Neurol, January 1, 2008; 65(1): 142 - 143.
[Full Text] [PDF]

Home page
 BrainHome page
A. P. D. Henderson, S. A. Trip, P. G. Schlottmann, D. R. Altmann, D. F. Garway-Heath, G. T. Plant, and D. H. Miller
An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography
Brain, January 1, 2008; 131(1): 277 - 287.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. A. Rocca, E. Pagani, M. Absinta, P. Valsasina, A. Falini, G. Scotti, G. Comi, and M. Filippi
Altered functional and structural connectivities in patients with MS: A 3-T study
Neurology, December 4, 2007; 69(23): 2136 - 2145.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. Pulicken, E. Gordon-Lipkin, L. J. Balcer, E. Frohman, G. Cutter, and P. A. Calabresi
Optical coherence tomography and disease subtype in multiple sclerosis
Neurology, November 27, 2007; 69(22): 2085 - 2092.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
D.S. Meier, H.L. Weiner, and C.R.G. Guttmann
MR Imaging Intensity Modeling of Damage and Repair In Multiple Sclerosis: Relationship of Short-Term Lesion Recovery to Progression and Disability
AJNR Am. J. Neuroradiol., November 1, 2007; 28(10): 1956 - 1963.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
I.-K. Penner, N. Bechtel, C. Raselli, M. Stocklin, K. Opwis, L. Kappos, and P. Calabrese
Fatigue in multiple sclerosis: relation to depression, physical impairment, personality and action control
Multiple Sclerosis, November 1, 2007; 13(9): 1161 - 1167.
[Abstract] [PDF]

Home page
 Mult SclerHome page
V. Tomassini, L. De Giglio, M. Reindl, P. Russo, I. Pestalozza, P. Pantano, T. Berger, and C. Pozzilli
Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS
Multiple Sclerosis, November 1, 2007; 13(9): 1086 - 1094.
[Abstract] [PDF]

Home page
 Mult SclerHome page
D. Pohlau, H. Przuntek, M. Sailer, F. Bethke, J. Koehler, N. Konig, C. Heesen, P. Spath, and I. Andresen
Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre study
Multiple Sclerosis, November 1, 2007; 13(9): 1107 - 1117.
[Abstract] [PDF]

Home page
 Mult SclerHome page
R.A. Marrie and M. Goldman
Validity of performance scales for disability assessment in multiple sclerosis
Multiple Sclerosis, November 1, 2007; 13(9): 1176 - 1182.
[Abstract] [PDF]

Home page
 NeurologyHome page
E. Gordon-Lipkin, B. Chodkowski, D. S. Reich, S. A. Smith, M. Pulicken, L. J. Balcer, E. M. Frohman, G. Cutter, and P. A. Calabresi
Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis
Neurology, October 16, 2007; 69(16): 1603 - 1609.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. G. Brown, S. Kirby, C. Skedgel, J. D. Fisk, T. J. Murray, V. Bhan, and I. S. Sketris
How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?
Neurology, October 9, 2007; 69(15): 1498 - 1507.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
M Liedorp, E Sanchez, I M W van Hoogstraten, B M E von Blomberg, F Barkhof, C H Polman, and J Killestein
No evidence of misdiagnosis in patients with multiple sclerosis and repeated positive anticardiolipin antibody testing based on magnetic resonance imaging and long term follow-up
J. Neurol. Neurosurg. Psychiatry, October 1, 2007; 78(10): 1146 - 1148.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
N. Figved, K.-M. Myhr, J.-P. Larsen, and D. Aarsland
Caregiver burden in multiple sclerosis: the impact of neuropsychiatric symptoms
J. Neurol. Neurosurg. Psychiatry, October 1, 2007; 78(10): 1097 - 1102.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
Z Khaleeli, J Sastre-Garriga, O Ciccarelli, D H Miller, and A J Thompson
Magnetisation transfer ratio in the normal appearing white matter predicts progression of disability over 1 year in early primary progressive multiple sclerosis
J. Neurol. Neurosurg. Psychiatry, October 1, 2007; 78(10): 1076 - 1082.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
M. Calabrese, N. De Stefano, M. Atzori, V. Bernardi, I. Mattisi, L. Barachino, A. Morra, L. Rinaldi, C. Romualdi, P. Perini, et al.
Detection of Cortical Inflammatory Lesions by Double Inversion Recovery Magnetic Resonance Imaging in Patients With Multiple Sclerosis
Arch Neurol, October 1, 2007; 64(10): 1416 - 1422.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
L. Benedetti, D. Franciotta, T. Vigo, M. Grandis, E. Fiorina, E. Ghiglione, L. Roccatagliata, G. L. Mancardi, A. Uccelli, and A. Schenone
Relapses After Treatment With Rituximab in a Patient With Multiple Sclerosis and Anti Myelin-Associated Glycoprotein Polyneuropathy
Arch Neurol, October 1, 2007; 64(10): 1531 - 1533.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
H. Ehrenreich, B. Fischer, C. Norra, F. Schellenberger, N. Stender, M. Stiefel, A.-L. Siren, W. Paulus, K.-A. Nave, R. Gold, et al.
Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis
Brain, October 1, 2007; 130(10): 2577 - 2588.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. K. Houtchens, R.H.B. Benedict, R. Killiany, J. Sharma, Z. Jaisani, B. Singh, B. Weinstock-Guttman, C. R.G. Guttmann, and R. Bakshi
Thalamic atrophy and cognition in multiple sclerosis
Neurology, September 18, 2007; 69(12): 1213 - 1223.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. P. Sormani, M. Rovaris, G. Comi, and M. Filippi
A composite score to predict short-term disease activity in patients with relapsing-remitting MS
Neurology, September 18, 2007; 69(12): 1230 - 1235.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Otaegui, S. Mostafavi, C. C. A. Bernard, A. L. de Munain, P. Mousavi, J. R. Oksenberg, and S. E. Baranzini
Increased Transcriptional Activity of Milk-Related Genes following the Active Phase of Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
J. Immunol., September 15, 2007; 179(6): 4074 - 4082.
[Abstract] [Full Text] [PDF]